Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luongo, C. L.
Right arrow Articles by Nibert, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luongo, C. L.
Right arrow Articles by Nibert, M. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 37, 23773-23780, September 11, 1998


Binding Site for S-Adenosyl-L-methionine in a Central Region of Mammalian Reovirus lambda 2 Protein
EVIDENCE FOR ACTIVITIES IN mRNA CAP METHYLATION*

Cindy L. LuongoDagger §, Carlo M. ContrerasDagger §parallel , Diane L. FarsettaDagger §**Dagger Dagger , and Max L. NibertDagger §§§

From the Dagger  Department of Biochemistry, the § Institute for Molecular Virology, and the ** Cellular and Molecular Biology Program, University of Wisconsin-Madison, Madison, Wisconsin 53706

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

One or more proteins in mammalian reovirus core particles mediate two RNA methylation activities, (guanosine-7-N)-methyltransferase and (guanosine-2'-O)-methyltransferase, that contribute to forming the 5' cap 1 structure on viral mRNA. We used UV irradiation to identify core proteins that bind S-adenosyl-L-methionine (SAM), the methyl-group donor for both methyltransferases. A [methyl-3H]SAM-binding site was observed among the reovirus lambda  proteins; was shown to be specific by competition with low levels of S-adenosyl-L-homocysteine, the product of methyl-group transfer from SAM; and was subsequently localized to protein lambda 2. lambda 2 mediates the guanylyltransferase reaction in cap formation and was previously proposed to mediate one or both methylation reactions as well. SAM binding was demonstrated for both lambda 2 in cores and lambda 2 expressed in insect cells from a recombinant baculovirus. Using three different methods to cleave lambda 2, a binding site for SAM was tentatively localized to a central region of lambda 2, between residues 792 and 1100, which includes a smaller region with sequence similarity to the SAM-binding pocket of other methyltransferases. Alanine substitutions at positions 827 and 829 within this predicted binding region greatly reduced the capacity of baculovirus-expressed lambda 2 protein to undergo UV cross-linking to SAM but had no effects on either the guanylyltransferase activity of this protein or its conformation as judged by partial proteolysis, suggesting that one or both of these residues is essential for SAM binding. Based on these findings, we propose that the two methyltransferase activities involved in mRNA capping by reovirus cores utilize a single SAM-binding pocket within a central region of lambda 2.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The first of four enzymes for forming the 5' cap 1 structure (m7-Gppp m2'-GpC[pN]n-OH) on each reovirus mRNA is an RNA triphosphate phosphohydrolase (1-3). This enzyme removes the gamma  phosphate from the 5'-terminal nucleotide of the nascent mRNA, a guanosine in all 10 reovirus mRNAs, generating a diphosphorylated terminus that serves as substrate for the RNA guanylyltransferase. The reovirus protein that mediates this activity in cores remains unproven; however, two proteins, lambda 1 and µ2, have been shown to influence the ion and temperature dependence of NTP hydrolysis by cores (4, 5), and a recombinant lambda 1 protein expressed in yeast has been shown to act in vitro as both NTPase (6) and RNA triphosphatase (7).

The next enzyme to act in cap formation is the RNA guanylyltransferase. The RNA guanylyltransferase activity mediated by core protein lambda 2 (8-10) was the focus of recent work in our lab.1 Previous work associated sequences near the N terminus of lambda 2 with this activity, particularly lysine 226, at which covalent linkage to GMP was found to occur as part of the catalytic mechanism exhibited by this and related enzymes (9, 11). We have recently shown that a 40-kDa N-terminal proteolytic fragment of lambda 2 can mediate both steps in the guanylyltransferase reaction: covalent linkage to GMP using GTP as substrate and transfer of GMP to an acceptor molecule, GDP or GTP in our experiments.1

Lastly, two methyltransferase activities act to form the final cap 1 structure on reovirus mRNAs (3, 12). Both activities appear to be mediated by reovirus-encoded proteins because no host proteins are known to be present in reovirus cores (13). The first is an RNA (guanosine-7-N)-methyltransferase, which uses S-adenosyl-L-methionine (SAM)2 as substrate for methyl-group transfer to the N-7 position of the RNA guanylyltransferase-added 5'-terminal guanosine (m7-GpppGpC[pN]n-OH) (2). The second is an RNA (guanosine-2'-O)-methyltransferase, which uses SAM as substrate for methyl-group transfer to the O-2' position of the 5'-most RNA polymerase-added nucleotide (m7-Gppp m2'-GpC[pN]n-OH). For both reactions, S-adenosyl-L-homocysteine (SAH) is formed as the by-product of methyl-group transfer from SAM. The reovirus protein that mediates these methylations has remained unproven, although the literature contains two suggestive findings. First, an observation reported as unpublished data by Seliger et al. (14) indicated that the lambda 2 protein was the only reovirus core protein that underwent covalent cross-linking to 8-azido-S-adenosyl [35S]methionine. Second, data base sequence comparisons by Koonin (15) revealed that lambda 2 contains sequences between residues 825 and 888 that bear similarities to other SAM-utilizing methyltransferases. Notably, this region of similarity includes sequences found in the SAM-binding pocket of methyltransferases for which such information is known (15).

Identification of the protein(s) that mediates methyltransferase reactions by reovirus cores is important for understanding how the capping enzymes are arranged in these particles. A confounding observation from previous work is that recombinant lambda 2 protein (rlambda 2) expressed from a vaccinia virus vector does not exhibit methyltransferase activity, possibly because it remains monomeric in solution (10) and does not adopt the pentameric structure observed for lambda 2 in cores (16). Having confirmed ourselves that rlambda 2 expressed from a baculovirus vector remains monomeric in solution and also fails to mediate methyltransferase activity,1 we turned to an alternative approach to address this potential activity of lambda 2. In this study, we used UV cross-linking in combination with protein fragmentation and site-directed mutagenesis to localize a binding site for [3H]SAM to a central region of lambda 2 sequence, overlapping that predicted by Koonin (15). Our results strongly suggest that lambda 2 mediates at least one of the two methylation reactions in mRNA capping by reovirus cores.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Purification of Virus Particles-- Virions of reovirus T1L or T3D were purified as described (17). Virion concentrations were determined from the relationship 1.0 A260 = 2.1 × 1012 virions/ml (18). Cores of reovirus T3D were prepared by digesting virions at a concentration of 3 × 1013 particles/ml with 200 µg/ml alpha -chymotrypsin (Sigma) for 1.5 h at 37 °C in virion buffer (10 mM Tris, pH 7.5, 10 mM MgCl2, 150 mM NaCl). Cores of reovirus T1L were chymotrypsin-digested as described (19). The chymotrypsin was inactivated with 1 mM phenylmethylsulfonyl fluoride (Sigma). To purify cores, digests were loaded onto a preformed CsCl gradient (rho  = 1.30-1.55 g/cm3) and subjected to equilibrium centrifugation. The particles were dialyzed into virion buffer. Modified cores were generated as described in Luongo et al. (20). In brief, 1 × 1013 cores of reovirus T3D in virion buffer were heated to 52 °C for 30 min, cooled to 37 °C, and treated with 200 µg/ml chymotrypsin for 10 min. Following treatment, the chymotrypsin was inactivated with 1 mM phenylmethylsulfonyl fluoride, and the modified cores were isolated following equilibrium centrifugation.

UV Cross-linking-- Reactions were UV irradiated using a modification of the procedure of Ahola et al. (21). In brief, 20-µl reactions containing the protein sample and 1.7 µCi of S-adenosyl-L-[methyl-3H]methionine ([3H]SAM) (80 Ci/mmol; DuPont) in 50 mM Tris-HCl, pH 7.5, 2 mM dithiothreitol, and 2 mM EDTA were pipetted into 0.5-ml microfuge tubes. The reactions were incubated on ice while being irradiated for 30 min with 254-nm UV light in a Stratalinker 2400 cross-linking oven (Stratagene, La Jolla, CA) with the samples placed 4 cm from the light source. We tested several variations to the reaction conditions in an effort to optimize the UV cross-linking of [3H]SAM to core proteins. For these studies, we used an assay in which protein-bound [3H]SAM was collected by precipitation with trichloroacetic acid after UV cross-linking and then detected by scintillation counting. The results (data not shown) suggested a pH optimum of pH 7.5, a preference for low concentrations of monovalent salts (<75 mM NaCl), and an insensitivity to low concentrations (10 mM) of divalent salts (MgCl2). Because these conditions were similar to those we had chosen to begin these studies, we continued to use the original conditions.

Polyacrylamide Gel Electrophoresis-- Protein samples were mixed with one-third volume of 3 × Laemmli loading buffer (3% SDS, 9% beta -mercaptoethanol, 375 mM Tris-HCl, pH 8.0, 30% sucrose, and 0.004% bromphenol blue) and heated at 100 °C for 2 min. The two identical samples were resolved on the same gel. The protein sample on one-half of the gel were visualized by staining with Coomassie Brilliant Blue (Sigma). For SDS-PAGE, the proteins in the other half of the gel were electroblotted to nitrocellulose (Bio-Rad) in 25 mM Tris, 192 mM glycine, pH 8.3. The nitrocellulose was coated with En3Hance spray surface autoradiography enhancer (DuPont), and the label was detected by fluorography. For the continuous phosphate-urea-SDS gels (7.5% acrylamide, 100 mM Na2PO4, pH 7.0, 20 mM EDTA, pH 8.0, M urea, 0.1% SDS) 1.5-mm-thick mini-gels (Bio-Rad) were run at 20 V for 18 h. To visualize radiolabel in the unstained half of the gel, it was treated with Intensify universal autoradiography enhancer (DuPont) and dried onto filter paper under vacuum prior to fluorography.

Expression and Proteolysis of rlambda 2-- The reovirus lambda 2 protein was expressed and purified as described in Luongo et al.1 In brief, recombinant baculovirus AcMNPV.T3DL2 was generated by transfection of Spodoptera frugiperda insect cells (Sf21, Invitrogen, Carlsbad, CA) with recombinant bacmid generated by cloning the L2 gene (22) into the pFastBacI vector (Life Technologies, Inc.). Trichoplusia ni insect cells (High Five, Invitrogen) were infected with AcMNPV.T3DL2 and harvested 48 h postinfection. Rlambda 2 protein was purified by anion exchange chromatography. To remove residual protein contaminants and concentrate rlambda 2, the column fractions were ammonium sulfate precipitated. For thermolysin-limited proteolysis of rlambda 2, the protein was diluted 10-fold with 50 mM Tris-HCl, pH 8.0, and placed on ice for 5 min. The protein was then placed at 4 °C and digested with a 5% volume of 2 mg/ml thermolysin (95 µg/ml final) (Sigma) for 30 min. The thermolysin was inactivated with 25 mM EDTA, pH 8.0.

Immunoblot Analysis-- Protein was electroblotted from SDS-polyacrylamide gels to nitrocellulose (Bio-Rad) in 25 mM Tris, 192 mM glycine, pH 8.3. Binding of the monoclonal antibody 7F4 was detected using goat anti-mouse IgG alkaline phosphate conjugate and colorimetric reagents 5-bromo-4-chloro-3 indoyl phosphate p-toluidine salt and p-nitro blue tetrazolium chloride (Bio-Rad). The molecular weight standards (kaleidoscope prestained) were purchased from Bio-Rad.

N-terminal Sequencing-- Proteolytic products of lambda 2 were transferred from an SDS-polyacrylamide gel to polyvinylidene fluoride paper (Applied Biosystems, Foster City, CA) (23), and the band corresponding to the 80K fragment was excised from the blot. N-terminal sequencing by Edman degradation was performed at the University of Michigan Protein and Carbohydrate Structure facility (Ann Arbor, MI).

Proteolytic Cleavage by Formate Treatment-- T3D cores at high concentration (1.2 × 1012) were incubated with [3H]SAM, subjected to UV cross-linking, and resolved on an 8% SDS-polyacrylamide gel. The lambda  protein band was excised and incubated in 75% formate (Sigma) (acid hydrolysis) or distilled water (control) at 37 °C for 16 h. The proteins were resolved on a 10% SDS-polyacrylamide gel and visualized as described above for UV cross-linked protein.

Generation of Mutant rlambda 2-- The L2 gene cloned into the BamHI site of pBluescript (Stratagene) was the template for site-directed mutagenesis utilizing the Quik Change site-directed mutagenesis kit (Stratagene). The complementary mutagenic primers 5'-CGTTGTGCTAGCTCTTGCGACGGGACCAGAGGC and 5'-GCCTCTGGTCCCGTCGCAAGAGCTAGCACAACG were used because the underlined nucleotides cause missense mutations that change both aspartate 827 and glycine 829 to alanine. In addition, these two alterations remove a BglII restriction site at nucleotide 2491. In brief, 50 ng of template was amplified with either 125 or 500 ng of each primer under the following conditions: 1 cycle at 94 °C for 30 s followed by 16 cycles at 94 °C for 30 s, 55 °C for 1 min, and 68 °C for 14 min followed by one cycle at 15 °C for 5 min. Mutant clones were identified by screening for the loss of the BglII site. The presence of the mutations were confirmed by sequencing both DNA strands from nucleotides 1804 to 3157 using the ABI Prism dye terminator cycle sequencing ready reaction kit (Applied Biosystems). No second site mutations were identified in this region, which encompasses the NsiI to NcoI fragment that was ligated with the 7.4-kilobase pair region of pFastBacI-L2 generated by digestion with NsiI and NcoI (New England Biolabs, Beverly, MA). Recombinant bacmid was generated and used to produce recombinant baculovirus by transfection of Sf21 cells. Mutant protein was expressed and purified as described for wild type lambda 2.

Autoguanylylation Assay-- The wild type and mutant rlambda 2 proteins were assayed for autoguanylylation activity by incubation of each protein with 5 µCi of [alpha -32P]GTP (DuPont) in 50 mM Tris, pH 8.0, 10 mM MgCl2, and 2 mM dithiothreitol for 30 min at room temperature. EDTA, pH 8.0, was added to a final concentration of 10 mM to halt the reaction. The proteins were resolved on a Tris-glycine-SDS 8% polyacrylamide gel, and the covalent protein-associated radiolabel was visualized by PhosphorImager analysis (Molecular Dynamics, Sunnyvale, CA).

Expression of Recombinant lambda 3 (rlambda 3)-- rlambda 3 was expressed using a recombinant baculovirus system as follows. The reovirus T3D L1 gene, which encodes the lambda 3 protein, cloned into the PstI site of pBR322 (22) was obtained from Michael Roner (Florida Atlantic University). The L1 gene was PCR amplified using the forward primer 5'-CGCGGGTACCTCGAGACGACCATGGCATCCATGATAC and the reverse primer 5'-CGCGGGTACCCATGGTAGACTCACGCTGAC. These primers add KpnI sites (underlined) 5' and 3' of the L1 coding sequence and XhoI and NcoI restriction sites (italicized), respectively, 5' of the L1 coding sequence. The Extend Long Template PCR system (Boehringer Mannheim) was used to amplify the L1 gene. In brief, buffer 2 supplemented to 5.25 mM MgCl2 (final) was used in the reaction. The amplification conditions were one cycle at 92 °C for 2 min followed by 10 cycles at 92 °C for 15 s, 60 °C for 35 s, and 68 °C for 3.5 min followed by 20 cycles at 92 °C for 15 s, 65 °C for 35 s, and 68 °C for 3 min 50 s with an addition of 20 s/cycle followed by one cycle at 68 °C for 7 min. The L1 PCR product was digested with XhoI and KpnI (New England Biolabs) and ligated into the pFastBacI vector digested with the same enzymes. Recombinant bacmid was generated and used to produce recombinant baculovirus by transfection of Sf21 cells. For protein expression, High Five cells were infected with 0.6 plaque forming units of L1 recombinant baculovirus and harvested 62-70 h postinfection. Cells were placed on ice and lysed in a hypotonic buffer (10 mM Tris, pH 7.4, 2.5 mM MgCl2, 0.5% Triton X-100, 100 mM NaCl, 2% complete protease inhibitor mixture (Boehringer Mannheim)). Nuclei and large cellular debris were pelleted at 200 × g for 15 min at 4 °C. The lambda 3 in the supernatant was partially purified by removal of protein contaminant by pretreatment with 20% (saturation at 0 °C) ammonium sulfate and precipitation. The protein precipitated by 35% ammonium sulfate contained lambda 3 and was resuspended in 50 mM Tris, pH 8.0. The resuspended protein was then used for UV cross-linking.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

UV Cross-linking of [3H]SAM to lambda 2 and/or lambda 3 Proteins in Reovirus Cores and Virions-- To identify which reovirus core proteins contain binding sites for SAM, core particles of reovirus T3D were incubated with [methyl-3H]SAM and irradiated with UV light (254 nm) to cross-link this molecule to its binding site(s). Following electrophoresis in a Tris-glycine-SDS gel (8% acrylamide), blotting to nitrocellulose to improve detection of 3H, and fluorography, radiolabel was strongly detected in the lambda protein band (Fig. 1A). In this type of gel, the lambda  band comprises core proteins lambda 1 (120 copies/particle), lambda 2 (60 copies/particle), and lambda 3 (12 copies/particle). When virions of reovirus T3D were treated in the same protocol, radiolabel was again strongly detected in the lambda  band and at similar levels as seen with cores (Fig. 1A). The latter result concurs with findings that the capping methyltransferases have nearly full activity in reovirus virions (24). Only minor amounts of radiolabel were associated with the major outer capsid proteins in virions, µ1C and sigma 3 (600 copies each per virion), providing evidence that the binding of [3H]SAM is specific to one or more of the lambda  proteins. The same results were obtained with cores and virions of reovirus T1L (data not shown), indicating that this property is not unique to a single reovirus strain.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 1.   UV cross-linking of [3H]SAM to proteins in reovirus particles. Cores (C) and virions (V) of reovirus T3D were UV irradiated, and the proteins were resolved by SDS-PAGE followed by Coomassie Brilliant Blue staining of one-half of the gel (left panel) or fluorography of an electroblot of the other half of the gel (right panel). The apparent molecular weights of protein standards (× 103) are indicated at far left. A, a Tris-glycine-SDS 8% polyacrylamide gel was used to resolve the lambda  band containing lambda 1, lambda 2, and lambda 3 proteins from the other proteins in reovirus particles. B, a phosphate-urea-SDS 7.5% polyacrylamide gel was used to separate the protein band containing lambda 2 and lambda 3 from the band containing lambda 1. The same numbers of cores and virions (3 × 1011) were utilized in the individual reactions.

To identify which lambda  proteins contain binding sites for SAM, core particles of reovirus T3D were incubated with [3H]SAM, irradiated with UV light to achieve cross-linking, and subjected to electrophoresis in a phosphate-urea-SDS gel (7.5% acrylamide). Such gels provide good separation of the lambda 1 protein from the lambda 2 and lambda 3 proteins, which still comigrate (18). Following fluorography, radiolabel was strongly detected in the lambda 2/lambda 3 band but not in the lambda 1 band (Fig. 1B). When virions of reovirus T3D were treated in the same protocol, radiolabel was again strongly detected in the lambda 2/lambda 3 band and at similar levels as observed with cores (Fig. 1B). The same results for cross-linking to [3H]SAM were obtained with cores and virions of reovirus T1L (data not shown). These results indicate that the primary binding sites for SAM identified by UV cross-linking are found in lambda 2 and/or lambda 3, and not in lambda 1, in both particle types of the two reovirus strains.

Competition by SAH and Optimization of [3H]SAM Binding to Reovirus lambda  Protein(s)-- Before proceeding with other studies to localize the binding site(s), we addressed the specificity of binding to SAM by the lambda  protein(s) in cores by performing competition experiments with nonradiolabeled SAH, the stable by-product of methyl-group transfer from SAM in the capping methyltransferase reaction (2). The capacity of SAH to inhibit methyltransferase activities in reovirus cores was previously demonstrated (25). In addition, competition by SAH has been used to demonstrate the specificity of binding to SAM by other methyltransferases (26-28). Using SDS-PAGE, electroblotting, and fluorography, we showed that radiolabeling of the lambda  protein(s) in reovirus T3D cores upon UV cross-linking in the presence of 1 µM [3H]SAM was inhibited by SAH with an IC50 of ~0.5 µM (Fig. 2A). In contrast, S-adenosyl-D-homocysteine (dextro form of SAH) had little or no effect on cross-linking to [3H]SAM at the highest concentration tested (5 µM) (data not shown), providing further evidence for the specificity of competition by the physiological, laevo form of SAH. These results provide evidence that cross-linking to [3H]SAM reflects the presence of one or more specific binding sites for SAM in lambda 2 and/or lambda 3.


View larger version (70K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of SAH and GpppG on [3H]SAM binding to lambda  proteins. Reovirus T3D cores (8 × 1011/reaction) were mixed with 1 µM [3H]SAM and various concentrations of unlabeled competitor SAH (A) or cap analog GpppG (B) and then UV irradiated. The core proteins were separated on Tris-glycine-SDS 8% polyacrylamide gels and visualized by Coomassie Brilliant Blue staining of one-half of each gel (left panels) or fluorography of the electroblotted other half of each gel (right panels). The apparent molecular weights of protein standards (× 103) are indicated at far left.

In an effort either to compete or to enhance SAM binding to the lambda  proteins in cores, we tested the effects of GTP and the cap analog GpppG. We hypothesized that GTP binding to the guanylyltransferase region of lambda 2 (9)1 or GpppG binding to one or both putative methyltransferase regions in lambda 2 (Refs. 14 and 15 and this study) might enhance the observed SAM binding activity. Nevertheless, when cross-linking to [3H]SAM was performed in the presence of up to 20 µM GTP (data not shown) or GpppG (Fig. 2B), SAM binding to lambda 2 and/or lambda 3 in T3D cores was unchanged, indicating that these compounds do not modulate this activity.

Localization of [3H]SAM Binding to a 120K N-terminal Portion of lambda 2 Protein in Modified Cores-- In an attempt to localize the binding site(s) for SAM in reovirus cores, we used modified cores containing lambda 2 protein that lacks 25K of C-terminal sequences due to sequential treatments with mild heat (52 °C) and chymotrypsin (20). After subjecting these modified cores to UV cross-linking in the presence of [3H]SAM, followed by SDS-PAGE and fluorography, we found the 120K N-terminal fragment of lambda 2 that is present in these particles to be strongly radiolabeled (Fig. 3). Because the complementary, 25K C-terminal region of lambda 2 is degraded as the modified cores are made (20), we could not address whether it, too, might contain a SAM-binding site; nonetheless, the available data demonstrate that at least one SAM-binding site is located within the 120K N-terminal portion of lambda 2. The data also indicate that this large N-terminal portion of lambda 2 is sufficient for at least one SAM-binding activity of lambda 2, consistent with previous findings that removing the C terminus of lambda 2 by treatment with heat and chymotrypsin does not reduce the capacity of modified cores to methylate newly transcribed viral mRNAs (20).


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 3.   UV cross-linking of [3H]SAM to the 120-kDa lambda 2 fragment of heat and chymotrypsin-modified cores. Cores (C) and heat and chymotrypsin-modified cores (H) (6 × 1011/reaction) were UV irradiated in the presence of [3H]SAM and resolved on a Tris-glycine-SDS 8% polyacrylamide gel. The 120K lambda 2 cleavage product is evident beneath the lambda  protein band in the Coomassie Brilliant Blue-stained half of the gel (left panel) and after fluorography of the electroblotted half of the gel (right panel). The apparent molecular weights of protein standards (× 103) are indicated at far left. The diagram in the bottom panel represents the pattern of lambda 2 cleavage in the modified cores. As shown, the 120K fragment represents the N-terminal portion of lambda 2 (20). The 25K C-terminal portion of lambda 2 (hatched) is not detectable because of its rapid degradation (20).

The small amount of radiolabel that was seen to migrate at the position of full-length lambda 2 protein after cross-linking with modified cores (Fig. 3) could represent the small amount of uncleaved lambda 2 protein that remains present in these particles and/or the lambda 3 protein, which fully resists cleavage during the heat and chymotrypsin treatments (20). Nonetheless, because radiolabel was mostly associated with the 120K fragment of lambda 2 after cross-linking with modified cores, the findings strongly suggest that any cross-linking of [3H]SAM to lambda 3 that may also have occurred with modified cores or cores was minor compared with that to lambda 2 (see last section of "Results" for additional analysis of lambda 3).

Localization of [3H]SAM Binding to a 55K C-terminal Portion of lambda 2 in Cores by Limited Hydrolysis with Formic Acid-- The deduced amino acid sequence of T3D lambda 2 protein includes four aspartate-proline pairs that should be sensitive to limited acid hydrolysis using 75% formic acid (29). The locations of these sites and the sizes of fragments that result from partial cleavage are shown in Fig. 4. After incubating with 75% formic acid to obtain cleavage of gel-isolated lambda 2 protein that had been previously cross-linked to [3H]SAM in T3D cores and then subjecting the products to a second round of SDS-PAGE, followed by electroblotting and fluorography, we observed a number of radiolabeled bands consistent with the expected fragments (Fig. 4). In particular, most radiolabel was associated with a band near 55K, the size of predicted fragment V from the C terminus of lambda 2. The next most prominent bands were ones near 60K (predicted fragment IV-V), 90K (predicted fragment III-V), and 120K (predicted fragment II-V). Fragments of similar sizes and relative intensities to these were detected in parallel samples analyzed by immunoblot using monoclonal antibody 7F4, confirming that these fragments all contain the C terminus of lambda 2. Gel-isolated lambda 2 protein, which had been previously cross-linked to [3H]SAM in T3D cores but which was incubated without formic acid prior to the second round of SDS-PAGE, served as a marker for full-length protein and was observed to be both radiolabeled and bound by 7F4 (Fig. 4). These findings strongly suggest that SAM is bound to one or more site within the C-terminal, 55-kDa fragment resulting from limited acid hydrolysis of lambda 2.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 4.   Limited formic-acid hydrolysis of lambda  protein after UV cross-linking to [3H]SAM. The lambda  proteins of T3D cores (1.2 × 1012 particles/reaction) that had been UV irradiated in the presence of [3H]SAM were incubated with water (F-) or 75% formic acid (F+) and then resolved on a Tris-glycine-SDS 10% polyacrylamide gel. The lambda  protein cleavage fragments were visualized by staining one-third of the gel with Coomassie Brilliant Blue (left panel). Cross-linking of [3H]SAM to protein was demonstrated by fluorography after electroblotting another third of the gel (middle panel). The identity of cleavage fragments containing the C terminus of lambda 2 was demonstrated by immunoblot analysis using the 7F4 monoclonal antibody (20, 30) (right panel). The four hypersensitive sites for acid hydrolysis in lambda 2 are diagrammed in the bottom panel along with the expected cleavage fragments (II-V, III-V, IV-V, and V) that contain the epitope in region V recognized by 7F4. Full-length lambda 2 and the cleavage fragments that appear to contain region V are identified in all three upper panels. The apparent molecular weights of protein standards (× 103) are indicated at far left.

UV Cross-linking of [3H]SAM to rlambda 2 Protein and Localization to an 80K C-terminal Portion of the Protein by Cleavage with Thermolysin-- To confirm the capacity of lambda 2 to bind SAM and to further localize the site of SAM binding in lambda 2, we performed experiments using a soluble, partially purified form of rlambda 2 that had been expressed in insect (Sf21 or High Five) cells from a recombinant baculovirus (AcMNPV) and shown to mediate the capping guanylyltransferase activity assigned to an N-terminal region of lambda 2.1 The rlambda 2 protein obtained in this manner was clearly visualized as a stained band after SDS-PAGE and was also strongly radiolabeled after UV cross-linking in the presence of [3H]SAM (Fig. 5, 0 time points). These findings demonstrated that the monomeric rlambda 2 binds SAM.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 5.   UV cross-linking of [3H]SAM to rlambda 2 and limited proteolysis with thermolysin. Purified rlambda 2 (3 µl) was untreated (0) or digested with 95 µg/ml thermolysin for the times indicated and then subjected to UV irradiation in the presence of [3H]SAM. The proteins were resolved on two Tris-glycine-SDS 8% polyacrylamide gels and visualized by Coomassie Brilliant Blue staining of one-half of one gel (left panel), fluorography of an electroblotted half of the same gel (middle panel), or immunoblot analysis using the 7F4 antibody of the second gel (right panel). The apparent molecular weights of protein standards (× 103) are indicated at far left for each gel. The diagram in the bottom panel shows the two thermolysin (THL) cleavage sites in lambda 2 that give rise to the 100K and 80K fragments observed in the gels, the position of the epitope recognized by 7F4, and the N-terminal sequence of the 80K fragment that was identified by Edman degradation.

In an effort to localize the site(s) of SAM binding in rlambda 2, we screened a variety of proteinases for limited proteolysis of rlambda 2 to yield distinct fragments. Thermolysin initially cleaved rlambda 2 to yield fragments with approximate sizes of 40K (data not shown) and 100K (Fig. 5). The 40K fragment was concluded to be derived from N-terminal sequences of lambda 2 based on its spontaneous, covalent labeling with [alpha -32P]GTP (data not shown), characteristic of the guanylyltransferase activity of this region (9).1 The 100K fragment was concluded to be the C-terminal complement of the 40K fragment based on its binding by monoclonal antibody 7F4 (20) (Fig. 5). As determined from time course analysis (data not shown), while this initial cleavage by thermolysin was continuing to occur in uncleaved copies of rlambda 2, both the 40K and 100K fragments became subject to additional cleavages. In the case of the 100K fragment, secondary cleavages occurred such that a stable 80K fragment was generated (Fig. 5). Because the 80K fragment is also recognized by 7F4 (Fig. 5), it must have retained its C-terminal sequences (20) and lost sequences from the middle of lambda 2. When thermolysin-cleaved rlambda 2 protein was subjected to UV cross-linking in the presence of [3H]SAM, radiolabeling of both the 100K and 80K fragments was observed (Fig. 5), localizing one or more SAM-binding site to the 80K C-terminal portion of lambda 2. To confirm which region of lambda 2 the 80K fragment represents, we subjected it to N-terminal sequencing. The sequence obtained by Edman degradation was leucine-alanine-arginine-proline-phenylalanine-proline (data not shown), corresponding to residues 562-567 in the deduced amino acid sequence of the T3D lambda 2 protein (14) and consistent with cleavage by thermolysin (N-terminal to leucine). The calculated mass of a fragment spanning residues 562-1289 (the C terminus of lambda 2) is 80.7 kDa, consistent with the observed Mr (80K).

The findings for localizing SAM-binding sites within either lambda 2 from cores or rlambda 2 using three different methods of proteinase or chemical cleavage can be summarized as follows. The SAM-binding fragments resulting from each of these treatments overlap sequences between positions 792, in the most C-terminal aspartate-proline pair in lambda 2, and ~1100, the site of lambda 2 truncation in cores treated with heat and chymotrypsin. Thus, if lambda 2 were to contain a single site for binding SAM that can be identified by UV cross-linking, this region (amino acids 792 to ~1100) would represent the likely location for this binding site. It is notable that this region includes the SAM-binding motif and adjacent sequences with similarity to known SAM-utilizing methyltransferases (residues 825-888) as described by Koonin (15).

Reduced Capacity of lambda 2 to Bind [3H]SAM after Alanine Substitutions at Positions 827 and 829-- To test the predictions of Koonin (15) regarding binding to SAM by residues near position 830 in lambda 2, as well as our own evidence that SAM is bound in this region, we created mutations in the pBluescript-inserted cDNA copy of T3D L2 (see "Experimental Procedures") such that the encoded lambda 2 protein contained two amino acid substitutions: alanine 827 (for aspartate in wild type lambda 2) and alanine 829 (for glycine in wild type lambda 2) in the B-B-aspartate-B-glycine-X-glycine motif (where B represents a hydrophobic residue and X represent any residue) shared by many methyltransferases (15). The mutant L2 gene was then used to generate a recombinant baculovirus for expressing the mutant lambda 2 protein in insect cells. Upon demonstrating that the mutant lambda 2 was expressed in these cells, we partially purified it using the same protocol as described for wild type lambda 2. The purified mutant and wild type lambda 2 proteins were then analyzed for SAM binding by incubation with [3H]SAM and UV cross-linking. The results indicate that the mutant lambda 2 protein is greatly diminished in its capacity to bind SAM (Fig. 6A). By quantitating the amounts of radiolabel associated with the wild type or mutant lambda 2 proteins with the amounts of each protein loaded in the gel lanes, we estimated that the mutant protein was labeled with [3H]SAM at <= 4% the level of wild type. The greatly reduced binding to SAM by the mutant lambda 2 was also demonstrated in a sample to which the 100K fragment of wild type lambda 2 (generated by prior thermolysin treatment) was added prior to cross-linking with [3H]SAM. In this case, the 100K fragment of wild type protein was strongly radiolabeled, and the full-length mutant protein again showed little detectable labeling above background. In contrast, the mutant lambda 2 protein was efficiently radiolabeled by covalent linkage to GM[32P] (Fig. 6B) as part of the guanylyltransferase reaction mediated by an N-terminal region of lambda 2 (9)1; was recognized by monoclonal antibody 7F4 (data not shown), which binds to a C-terminal epitope in lambda 2 (20, 30); and exhibited an identical pattern of cleavage upon treatment with thermolysin as the wild type protein (data not shown), indicating that other regions of lambda 2 were not substantially affected by the alanine substitutions at 827 and 829. Because mutations at these two closely spaced positions in lambda 2 so greatly reduced binding to SAM in the cross-linking assay but did not affect other properties, the results provide evidence that a single SAM-binding site in lambda 2, involving residues near position 830, was identified and analyzed in this study.


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 6.   Analysis of [3H]SAM binding and guanylyltransferase activity for an alanine substitution mutant of rlambda 2. The apparent molecular weights of protein standards (× 103) are indicated at far left. A, UV cross-linking was undertaken for 2 µl of wild type rlambda 2 (w) or 2 µl of mutant rlambda 2 (m). In addition, UV cross-linking of 5.5 µl of digest containing the 100K and 80K fragments of rlambda 2 (generated by treatment with thermolysin for 1 h at 4 °C) was undertaken in the absence (-) or presence (+) of mutant rlambda 2. The proteins were resolved on a Tris-glycine-SDS 8% polyacrylamide gel. Coomassie Brilliant Blue staining of one-half of the gel (left panel) and fluorography of an electroblot of the other half of the gel (right panel) were used to visualize the proteins. B, wild type (w) or mutant (m) rlambda 2 was incubated with [alpha -32P]GTP and resolved on a Tris-glycine-SDS 8% polyacrylamide gel to demonstrate covalent linkage to GM[32P] in association with guanylyltransferase activity. The gel was stained with Coomassie Brilliant Blue (left panel), and the protein-associated radiolabel was visualized by PhosphorImager (right panel). The alanine substitutions at amino acids 827 and 829 within the SAM-binding motif of lambda 2 are shown in the bottom panel.

No UV Cross-linking to [3H]SAM by rlambda 3 Protein-- Because lambda 2 and lambda 3 comigrate in phosphate-urea-SDS gels, the results for UV cross-linking of [3H]SAM to proteins in reovirus cores (Fig. 1B) leave open to question whether lambda 3 might also contain a binding site for SAM. Similarly, the small amount of [3H]SAM-labeled protein observed in the position of full-length lambda 2 and lambda 3 proteins from cores modified by previous treatment with mild heat and chymotrypsin (Fig. 3) could represent lambda 3 and/or a small amount of uncleaved lambda 2. To address more directly whether lambda 3 might also bind SAM, we used a recombinant form of the T3D lambda 3 protein that was expressed in insect cells from a recombinant baculovirus. The rlambda 3 protein was partially purified using a combination of ammonium sulfate precipitation and anion exchange chromatography (see "Experimental Procedures") and was shown to have poly(C)-dependent poly(G) polymerase activity (data not shown) (31). When partially purified preparations of rlambda 2 (see above) and rlambda 3 were subjected to UV cross-linking in the presence of [3H]SAM and then analyzed by SDS-PAGE, electroblotting, and fluorography, SAM bound to rlambda 2 and its 100K fragment (generated by a contaminating proteinase in this protein preparation1) but not to rlambda 3 (Fig. 7). Thus, the results for baculovirus-expressed rlambda 2 and rlambda 3 proteins, coupled with the results for proteins in cores, suggest that lambda 3 exhibits little if any binding to [3H]SAM using the UV cross-linking assay.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 7.   UV cross-linking assay for rlambda 3 in the presence of [3H]SAM. Partially cleaved rlambda 2 (1 µl at 1×) or uncleaved rlambda 3 (5 µl at 1×) at the amounts indicated were UV irradiated in the presence of [3H]SAM. The proteins were resolved on Tris-glycine-SDS 8% polyacrylamide gel and visualized by Coomassie Brilliant Blue staining of one-half of the gel (left panel) and fluorography of an electroblot of the other half of the gel (right panel). The apparent molecular weights of protein standards (× 103) are indicated at far left.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Three different fragmentation methods were used to localize binding sites for SAM in the reovirus lambda 2 protein. In the first, involving C-terminally truncated lambda 2 protein in modified cores, a site was localized between the N terminus and a position near residue 1100. In the second, involving limited acid hydrolysis of lambda 2 in cores, a site was localized between position 792 and the C terminus. In the third, involving thermolysin cleavage of rlambda 2, a site was localized between position 562 and the C terminus. Recognizing that these localizations overlap a region of lambda 2 between positions 792 and ~1100, we hypothesized that one or more binding site for SAM is located within this specific 35-kDa, central region of the protein. Although it is formally possible that more than one SAM-binding site is contained within this region, no candidate sequences are evident besides those identified by Koonin (15) between positions 825 and 888. Moreover, because the alanine substitutions we introduced at positions 827 and 829 within this region so greatly reduced the capacity of rlambda 2 to undergo UV cross-linking to [3H]SAM, the findings suggest that a single SAM-binding site involving amino acids near position 830 in lambda 2 has been identified by UV cross-linking in this study. Although it is tempting to state more definitively that lambda 2 contains only the one SAM-binding site, an important caveat is that a second SAM-binding site in lambda 2 may be less efficiently cross-linked to [3H]SAM in our protocol than the site we have studied and may in fact account for the very low level of activity (<= 4% wild type levels) we found remaining in the alanine substitution mutant. Another possibility is that the alanine substitutions at positions 827 and 829 knocked out two distinct or overlapping SAM-binding sites in lambda 2 at the same time. Thus, whereas we obtained no strong evidence for a second SAM-binding site in lambda 2, we cannot definitively rule out that possibility.

Region of lambda 2 Sufficient for SAM Binding-- We conceived of other experiments involving expression of lambda 2 or portions of that protein in Escherichia coli in an effort to identify the minimal region of lambda 2 that is necessary for SAM binding. The full-length lambda 2 protein and six deletion mutants expressed to date, however, have been found to be mostly insoluble, not readily solubilized, and inactive at SAM binding in the cross-linking assay (data not shown). Similar difficulties with lambda 2 expression in E. coli have been described by other investigators (9). Thus, we abandoned that approach for any further experiments in the current study.

On the other hand, the findings from partial proteolysis of intact lambda 2 described in this paper, which suggest that a central region of lambda 2 contains a SAM-binding site, can be considered in light of other findings to suggest that a region from 562 to ~1100 is sufficient for SAM binding. Because the ~25K C-terminal portion of lambda 2 is degraded in generating the 120K N-terminal fragment in cores treated with heat and chymotrypsin (20) and because the 120K fragment can subsequently bind SAM and undergo cross-linking to it (Fig. 3), the ~25K C-terminal portion must be dispensable for at least one SAM-binding activity. In addition, because the 40K N-terminal and 100K C-terminal fragments that can be generated from baculovirus-expressed lambda 2 protein by mild proteolysis with several proteinases1 including thermolysin (Fig. 5) are physically separated according to both native gel electrophoresis and gel filtration chromatography1, because the 20K N-terminal portion of the 100K thermolysin-generated fragment is degraded in generating the 80K fragment at later times of thermolysin treatment (data not shown), and because the 80K fragment can bind SAM and undergo cross-linking to it after proteolysis (Fig. 5), the N-terminal ~60K region of lambda 2 must also be dispensable for for at least one SAM binding activity. Thus, our data suggest that an ~60-kDa portion of lambda 2 spanning amino acids 562 to ~1100 constitutes the smallest region of the protein defined to date as being sufficient for SAM binding and UV cross-linking.

Implications for lambda 2 Function as a Capping Methyltransferase-- Biochemical evidence for SAM binding by lambda 2 supports a general expectation (14, 15) that lambda 2 mediates one or both of the RNA methylation activities (RNA (guanosine-7-N)-methyltransferase and RNA (guanosine-2'-O)-methyltransferase) in forming a 5' cap 1 structure on reovirus mRNA. Nevertheless, the failure of rlambda 2 to exhibit methylation activity (Ref. 10 and data not shown) still limits studies to dissect the putative methyltransferase activities of lambda 2 at a molecular level. This failure may reflect the incapacity of rlambda 2 expressed in isolation from other reovirus proteins to adopt the pentameric structure observed for lambda 2 in cores (10) (see next section).

Despite the caveat mentioned in the preceding section, an interesting possibility that can be inferred from the evidence for a single SAM-binding site in lambda 2 is that the same region of lambda 2 sequence may provide binding to SAM for the two different cap methylation activities in reovirus cores. An example similar to this possibility is seen in the multi-specific DNA methyltransferases of certain bacteriophages. In these enzymes, one polypeptide chain includes a single SAM-binding pocket and a single set of catalytic residues for methylation but multiple DNA-binding sites that allow specific recognition and subsequent methylation of several different DNA sequence motifs (32). Thus, different DNA-binding regions are arranged in those proteins such that each of the different DNA targets can be effectively bound and presented to the same catalytic machinery for methylation of defined bases within them. A similar hypothesis for lambda 2 would be that there are two different sequence regions in the protein that bind the nascent cap at the 5' end of reovirus mRNA, one region that binds GpppGpC[pN]n-OH and presents the base of the terminal guanosine for methylation at the N-7 position and another region that binds m7-GpppGpC[pN]n-OH (cap 0) and presents the sugar of the penultimate guanosine for methylation at the O-2' position (Fig. 8). Both substrates are methylated by catalytic machinery using the same SAM-binding pocket. Another possibility is that once the first methylation occurs, that is, once m7-GpppGpC[pN]n-OH is generated, this new RNA acceptor may undergo a change in orientation rather than translocating the RNA to a distinct binding site, such that the sugar of the penultimate guanosine is now properly presented for methylation at the O-2' position. This rearrangement might involve conformational changes in lambda 2, m7-GpppGpC[pN]n-OH, or both, possibly due to the presence of the (guanosine-7-N)-methyl group. The presence of one or two sites in lambda 2 for binding RNA acceptors is testable, and such experiments are in progress.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 8.   Model for a single SAM binding pocket associated with putative RNA (guanosine-7-N)-and (guanosine-2'-O)-methyltransferase activities in lambda 2. SAM is shown in its binding pocket (dark gray rectangle) identified in the central portion of lambda 2. The methyl group that is transferred to the RNA is indicated on the SAM molecule. Catalytic residues for methyl transfer are represented by the gray oval. The GpppG binding region is indicated by a rectangle with straight corners, and the m7-GpppG binding region is indicated by a rectangle with rounded corners. The RNA is represented in bold letters. According to the model shown here, lambda 2 contains two methyltransferase-associated RNA-binding regions for binding either a GpppG or a mGpppG RNA terminus. In the upper panel, the methyl group of the bound SAM is transferred (curved arrow) to the N-7 position of the terminal G residue of the RNA bound in the GpppG binding region to generate m7-GpppGpC[pN]n-OH RNA (cap 0) and SAH, both of which are released from lambda 2. As shown in the lower panel, the m7-GpppGpC[pN]n-OH RNA then binds in the mGpppG binding region of lambda 2 and a second SAM molecule binds in the SAM binding pocket (as shown by the arrow). The methyl group of the bound SAM is transferred (curved arrow) to the O-2' position of the penultimate G residue to generate m7-Gppp m2'-GpC[pN]n-OH RNA and SAH, both of which are released from lambda 2.

The circumstance suggested in Fig. 8 for lambda 2, one SAM binding site for the two methylation reactions, has not been described for a capping methyltransferase to date. For example, the (guanosine-7-N)-methyltransferase and (nucleoside-2'-O)-methyltransferase activities of vaccinia virus are mediated by distinct proteins (33, 34). Similarly, the capping methyltransferase encoded by the ABD1 gene of Saccharomyces cerevisiae has been shown to act as a (guanosine-7-N)-methyltransferase but not as a (nucleoside-2'-O)-methyltransferase (27). Thus, a detailed analysis of the SAM binding and methyltransferase activities of lambda 2 may provide unique insights into this class of enzymes.

Relationship of Findings to Pentameric Structure of Core-bound lambda 2-- The arrangement of lambda 2 as homopentamers in reovirus cores has been known for some time (35, 36) although visualized at higher resolution only recently by cryoelectron microscopy with (16, 20) or without (37) three-dimensional image reconstruction. The regions of lambda 2 that are essential for pentamerization remain undefined; however, the aforementioned three-dimensional reconstructions suggest that regions at the intermediate radii spanned by lambda 2 (which extends radially over ~100 Å in reovirus cores) may be most important.1 Although the SAM-binding pocket is functionally constituted by a lambda 2 monomer, as shown in this study, it is conceivable that residues in lambda 2 that contribute to catalysis and/or to binding RNA acceptor molecules in association with the SAM-binding pocket (Fig. 8) may be contributed by an adjacent monomer in the core-bound, pentameric lambda 2. This requirement would provide one possible explanation for why monomeric lambda 2 does not exhibit methyltransferase activity. A related, though distinct, possibility is that the residues necessary to constitute each active methyltransferase unit are contributed by the same lambda 2 monomer but that interactions with adjacent monomers in the lambda 2 pentamer are necessary for permitting these residues to assume their catalytically active conformations. These putative interactions between adjacent lambda 2 monomers are apparently not required for forming a functional SAM-binding site, however, as we show in this study using monomeric rlambda 2 obtained from insect cells.

    ACKNOWLEDGEMENTS

We thank K. L. Tyler and H. W. Virgin, IV, for purified stocks of monoclonal antibody 7F4. We also thank S. J. Harrison, R. Leidner, J. J. Lugus, and X.-H. Zhou for technical support; T. J. Broering, A. L. Gillian, S. C. Harrison, and K. M. Reinisch for helpful discussions and reviews of a preliminary manuscript; and S. Shuman for other helpful discussion.

    FOOTNOTES

* This work was supported by National Institutes of Health Public Health Service Grant R29 AI39533 (to M. L. N.) and by National Research Service Award F32 18409A (to C. L. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by National Institutes of Health Grant T32 CA09075 to the Viral Oncology Training Program (University of Wisconsin-Madison).

parallel Supported by a Hilldale Fellowship from the University of Wisconsin-Madison.

Dagger Dagger Supported by National Institutes of Health Grant T32 GM08349 to the Biotechnology Training Program (University of Wisconsin-Madison).

§§ Supported by a Shaw Scientist Award from the Milwaukee Foundation (Milwaukee, WI). To whom correspondence should be addressed: Inst. for Molecular Virology, University of Wisconsin-Madison, 1525 Linden Dr., Madison, WI 53706. Tel.: 608-262-4536; Fax: 608-262-7414; E-mail: mlnibert{at}facstaff.wisc.edu.

The abbreviations used are: SAM, S-adenosyl-L-methionineSAH, S-adenosyl-L-homocysteinerlambda 2, recombinant lambda 2[3H]SAM, [methyl-3H]S-adenosyl-L-methioninerlambda 3, recombinant lambda 3PAGE, polyacrylamide gel electrophoresisPCR, polymerase chain reaction.

1 C. L. Luongo, K. M. Reinisch, S. C. Harrison, and M. L. Nibert, manuscript in preparation.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Banerjee, A. K., Ward, R., and Shatkin, A. J. (1971) Nat. New Biol. 230, 169-172[CrossRef][Medline] [Order article via Infotrieve]
  2. Furuichi, Y., Muthukrishnan, S., Tomasz, J., and Shatkin, A. J. (1976) J. Biol. Chem. 251, 5043-5053[Abstract/Free Full Text]
  3. Shatkin, A. J., and Kozak, M. (1983) in The Reoviridae (Joklik, W. K., ed), pp. 79-106, Plenum Press, New York
  4. Noble, S., and Nibert, M. L. (1997) J. Virol. 71, 2182-2191[Abstract]
  5. Noble, S., and Nibert, M. L. (1997) J. Virol. 71, 7728-7735[Abstract]
  6. Bisaillon, M., Bergeron, J., and Lemay, G. (1997) J. Biol. Chem. 272, 18298-18303[Abstract/Free Full Text]
  7. Bisaillon, M., and Lemay, G. (1997) J. Biol. Chem. 272, 29954-29957[Abstract/Free Full Text]
  8. Cleveland, D. R., Zarbl, H., and Millward, S. (1986) J. Virol. 60, 307-311[Abstract/Free Full Text]
  9. Fausnaugh, J., and Shatkin, A. J. (1990) J. Biol. Chem. 265, 7669-7762[Abstract/Free Full Text]
  10. Mao, Z. X., and Joklik, W. K. (1991) Virology 185, 377-386[CrossRef][Medline] [Order article via Infotrieve]
  11. Shuman, S., and Schwer, B. (1995) Mol. Microbiol. 17, 405-410[Medline] [Order article via Infotrieve]
  12. Furuichi, Y., Morgan, M., Muthukrishnan, S., and Shatkin, A. J. (1975) Proc. Natl. Acad. Sci. U. S. A. 72, 362-366[Abstract/Free Full Text]
  13. Shatkin, A. J. (1974) Proc. Natl. Acad. Sci. U. S. A. 71, 3204-3207[Abstract/Free Full Text]
  14. Seliger, L. S., Zheng, K., and Shatkin, A. J. (1987) J. Biol. Chem. 262, 16289-16293[Abstract/Free Full Text]
  15. Koonin, E. V. (1993) J. Gen. Virol. 74, 733-740[Abstract/Free Full Text]
  16. Dryden, K. A., Wang, G., Yeager, M., Nibert, M. L., Coombs, K. M., Furlong, D. B., Fields, B. N., and Baker, T. S. (1993) J. Cell Biol. 122, 1023-1041[Abstract/Free Full Text]
  17. Furlong, D. B., Nibert, M. L., and Fields, B. N. (1988) J. Virol. 62, 246-256[Abstract/Free Full Text]
  18. Smith, R. E., Zweerink, H. J., and Joklik, W. K. (1969) Virology 39, 791-810[CrossRef][Medline] [Order article via Infotrieve]
  19. Dryden, K. A., Farsetta, D. L., Wang, G.-J., Keegan, J. M., Fields, B. N., Baker, T. S., and Nibert, M. L. (1998) Virology 225, 33-46
  20. Luongo, C. L., Dryden, K. A., Farsetta, D. L., Margarf, R. M., Severson, T. F., Olson, N. H., Fields, B. N., Baker, T. S., and Nibert, M. L. (1997) J. Virol. 71, 8035-8040[Abstract]
  21. Ahola, T., Laakkonen, P., Vihinen, H., and Kaariainen, L. (1997) J. Virol. 71, 392-397[Abstract]
  22. Cashdollar, L. W., Chmelo, R., Esparza, J., Hudson, G. R., and Joklik, W. K. (1984) Virology 133, 191-196[CrossRef][Medline] [Order article via Infotrieve]
  23. Nibert, M. L., and Fields, B. N. (1992) J. Virol. 66, 6408-6418[Abstract/Free Full Text]
  24. Yamakawa, M., Furuichi, Y., and Shatkin, A. J. (1982) Virology 118, 157-168[CrossRef][Medline] [Order article via Infotrieve]
  25. Furuichi, Y., and Shatkin, A. J. (1976) Proc. Natl. Acad. Sci. U. S. A. 73, 3448-3452[Abstract/Free Full Text]
  26. Higman, M. A., and Niles, E. G. (1994) J. Biol. Chem. 269, 14982-14987[Abstract/Free Full Text]
  27. Mao, X., Schwer, B., and Shuman, S. (1995) Mol. Cell Biol. 15, 4167-4174[Abstract]
  28. Liao, H. J., and Stollar, V. (1997) Virology 228, 19-28[CrossRef][Medline] [Order article via Infotrieve]
  29. Anders, D. G., and Consigli, R. A. (1983) J. Virol. 48, 197-205[Abstract/Free Full Text]
  30. Virgin, H. W., IV, Mann, M. A., Fields, B. N., and Tyler, K. L. (1991) J. Virol. 65, 6772-6781[Abstract/Free Full Text]
  31. Starnes, M. C., and Joklik, W. K. (1993) Virology 193, 356-366[CrossRef][Medline] [Order article via Infotrieve]
  32. Lange, C., Jugel, A., Walter, J., and Noyer-Weidner, M. (1991) Nature 352, 645-648[CrossRef][Medline] [Order article via Infotrieve]
  33. Shuman, S., and Moss, B. (1990) Methods Enzymol. 181, 170-180[Medline] [Order article via Infotrieve]
  34. Schnierle, B. S., Gershon, P. D., and Moss, B. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 2897-2901[Abstract/Free Full Text]
  35. White, C. K., and Zweerink, H. J. (1976) Virology 70, 171-180[CrossRef][Medline] [Order article via Infotrieve]
  36. Ralph, S. J., Harvey, J. D., and Bellamy, A. R. (1980) J. Virol. 36, 894-896[Abstract/Free Full Text]
  37. Centonze, V. E., Chen, Y., Severson, T. F., Borisy, G. G., and Nibert, M. L. (1995) J. Struct. Biol. 115, 215-225[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
A. M. Murphy and V. Z. Grdzelishvili
Identification of Sendai Virus L Protein Amino Acid Residues Affecting Viral mRNA Cap Methylation
J. Virol., February 15, 2009; 83(4): 1669 - 1681.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Decroly, I. Imbert, B. Coutard, M. Bouvet, B. Selisko, K. Alvarez, A. E. Gorbalenya, E. J. Snijder, and B. Canard
Coronavirus Nonstructural Protein 16 Is a Cap-0 Binding Enzyme Possessing (Nucleoside-2'O)-Methyltransferase Activity
J. Virol., August 15, 2008; 82(16): 8071 - 8084.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kroschewski, S. P. Lim, R. E. Butcher, T. L. Yap, J. Lescar, P. J. Wright, S. G. Vasudevan, and A. D. Davidson
Mutagenesis of the Dengue Virus Type 2 NS5 Methyltransferase Domain
J. Biol. Chem., July 11, 2008; 283(28): 19410 - 19421.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. E. Murray and M. L. Nibert
Guanidine Hydrochloride Inhibits Mammalian Orthoreovirus Growth by Reversibly Blocking the Synthesis of Double-Stranded RNA
J. Virol., May 1, 2007; 81(9): 4572 - 4584.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Li, J. T. Wang, and S. P. J. Whelan
A unique strategy for mRNA cap methylation used by vesicular stomatitis virus
PNAS, May 30, 2006; 103(22): 8493 - 8498.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Z. Grdzelishvili, S. Smallwood, D. Tower, R. L. Hall, D. M. Hunt, and S. A. Moyer
A Single Amino Acid Change in the L-Polymerase Protein of Vesicular Stomatitis Virus Completely Abolishes Viral mRNA Cap Methylation
J. Virol., June 15, 2005; 79(12): 7327 - 7337.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
F. M. Jaafar, H. Attoui, P. P. C. Mertens, P. de Micco, and X. de Lamballerie
Identification and functional analysis of VP3, the guanylyltransferase of Banna virus (genus Seadornavirus, family Reoviridae)
J. Gen. Virol., April 1, 2005; 86(4): 1141 - 1146.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. L. Hermann and K. M. Coombs
Inhibition of Reovirus by Mycophenolic Acid Is Associated with the M1 Genome Segment
J. Virol., June 15, 2004; 78(12): 6171 - 6179.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. J. Broering, J. Kim, C. L. Miller, C. D. S. Piggott, J. B. Dinoso, M. L. Nibert, and J. S. L. Parker
Reovirus Nonstructural Protein {micro}NS Recruits Viral Core Surface Proteins and Entering Core Particles to Factory-Like Inclusions
J. Virol., February 15, 2004; 78(4): 1882 - 1892.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Kim, J. S. L. Parker, K. E. Murray, and M. L. Nibert
Nucleoside and RNA Triphosphatase Activities of Orthoreovirus Transcriptase Cofactor {micro}2
J. Biol. Chem., February 6, 2004; 279(6): 4394 - 4403.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y.-L. Huang, Y.-T. Han, Y.-T. Chang, Y.-H. Hsu, and M. Meng
Critical Residues for GTP Methylation and Formation of the Covalent m7GMP-Enzyme Intermediate in the Capping Enzyme Domain of Bamboo Mosaic Virus
J. Virol., February 1, 2004; 78(3): 1271 - 1280.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Kim, X. Zhang, V. E. Centonze, V. D. Bowman, S. Noble, T. S. Baker, and M. L. Nibert
The Hydrophilic Amino-Terminal Arm of Reovirus Core Shell Protein {lambda}1 Is Dispensable for Particle Assembly
J. Virol., October 25, 2002; 76(23): 12211 - 12222.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. J. Broering, A. M. McCutcheon, V. E. Centonze, and M. L. Nibert
Reovirus Nonstructural Protein {micro}NS Binds to Core Particles but Does Not Inhibit Their Transcription and Capping Activities
J. Virol., June 15, 2000; 74(12): 5516 - 5524.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. L. Luongo, K. M. Reinisch, S. C. Harrison, and M. L. Nibert
Identification of the Guanylyltransferase Region and Active Site in Reovirus mRNA Capping Protein lambda 2
J. Biol. Chem., January 28, 2000; 275(4): 2804 - 2810.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. L. Farsetta, K. Chandran, and M. L. Nibert
Transcriptional Activities of Reovirus RNA Polymerase in Recoated Cores. INITIATION AND ELONGATION ARE REGULATED BY SEPARATE MECHANISMS
J. Biol. Chem., December 8, 2000; 275(50): 39693 - 39701.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luongo, C. L.
Right arrow Articles by Nibert, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luongo, C. L.
Right arrow Articles by Nibert, M. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement